Jaguar Animal Health, Inc. (JAGX) Trading Down NaN

Jaguar Animal Health, Inc. (NASDAQ:JAGX)’s share price was down NaN during trading on Thursday . The stock traded as low as $0.17 and last traded at $0.00. Approximately 819,726 shares were traded during trading, an increase of Infinity from the average daily volume of 0 shares.

Several equities analysts recently commented on JAGX shares. Rodman & Renshaw started coverage on shares of Jaguar Animal Health in a research note on Tuesday, July 11th. They set a “buy” rating and a $2.00 target price for the company. HC Wainwright set a $2.00 target price on shares of Jaguar Animal Health and gave the company a “buy” rating in a research note on Tuesday, July 11th.

COPYRIGHT VIOLATION WARNING: “Jaguar Animal Health, Inc. (JAGX) Trading Down NaN” was published by Community Financial News and is owned by of Community Financial News. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.com-unik.info/2017/11/03/jaguar-animal-health-inc-jagx-trading-down-nan.html.

About Jaguar Animal Health

Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

What are top analysts saying about Jaguar Animal Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Jaguar Animal Health Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit